{
 "PrintNo":"S276","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2020-12-23T16:31:35.573958Z",
 "Status":"IN_SENATE_COMM","Committee":"Consumer Protection",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Consumer Protection"}],
 "Actions":[
  {"Text":"REFERRED TO CONSUMER PROTECTION","Date":"2021-01-06","Chamber":"SENATE"},
  {"Text":"REFERRED TO CONSUMER PROTECTION","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1228,"Name":"Zellnor Myrie","Short":"MYRIE"}],
 "Title":"Provides for the proper packaging and labeling of pharmaceutical drugs; creates penalties for intentional fraud",
 "Summary":"Provides for the proper packaging and labeling of pharmaceutical drugs; creates penalties for intentional fraudulent replacement, packaging, and labeling of such drugs; provides for better consumer protection.",
 "LawSection":"General Business Law","LawCode":"Add ยง392-k, Gen Bus L",
 "ActClause":"AN ACT to amend the general business law, in relation to preserving the integrity and safety of pharmaceutical drugs",
 "SameAsPrintNo":"A1156-2021","PreviousVersions":["S3164-2019"]
}